Back to mobile site

More on LCTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+84.6% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Lineage Cell Therapeutics (NY:LCTX)
Delayed: 1.27 -0.01 (0.78%)
Prev. Close $1.28  
Open$1.29 
52 Wk High$ 
52 Wk Low$ 
Day High$1.31 
Day Low$1.26 
P/E N/A  
EPS$ 
Volume1,018,885 

Friends, Peers and Foes (?): RHHBY (more...)

May 12, 2026 04:01 PM Lineage Cell Therapeutics (LCTX) Misses Q1 EPS by 2c
May 12, 2026 04:01 PM Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 5, 2026 08:00 AM Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026
May 4, 2026 08:00 AM OpRegen® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026
Apr 28, 2026 06:37 AM Canaccord Starts Lineage Cell Therapeutics Inc. (LCTX) at Buy
Apr 13, 2026 08:02 AM Lineage Cell Therapeutics forms scientific advisory board
Apr 13, 2026 08:00 AM Lineage Announces Formation of Scientific Advisory Board
Mar 25, 2026 08:00 AM Lineage Cell Therapeutics Inc. (LCTX) PT Raised to $4 at B.Riley
Mar 24, 2026 08:00 AM Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease
Mar 11, 2026 09:04 AM Lineage Cell Therapeutics (LCTX) files $100M mixed shelf
View All Articles

Entities mentioned with LCTX

View All Entities